Giuseppe Crescimanno Selected Research

Giuseppe Crescimanno Research Topics

5	Parkinson Disease (Parkinson's Disease) 01/2019 - 06/2007
3	Pain (Aches) 09/2019 - 08/2012
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Tics (Tic) 01/2017
1	Movement Disorders (Movement Disorder) 01/2008
1	Motor Disorders 01/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2007

3	Oxidopamine (6 Hydroxydopamine)IBA 01/2019 - 02/2009
2	Morphine (MS Contin)FDA LinkGeneric 09/2019 - 08/2016
1	EndocannabinoidsIBA 01/2022
1	CannabinoidsIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	Pharmaceutical PreparationsIBA 08/2012
1	Diazepam (Valium)FDA LinkGeneric 08/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2009
1	Dopamine (Intropin)FDA LinkGeneric 02/2009
1	Serotonin (5 Hydroxytryptamine)IBA 01/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2007

1	Analgesia 08/2016
1	Therapeutics 06/2007